Carboquone


Concise Prescribing Info
Indications/Uses
Chronic myeloid leukaemia.
Dosage/Direction for Use
Adult : PO Initial doses for remission induction: 1-2 mg/day. Maintenance: 0.25-0.75 mg every other day or twice wkly; adjust dose to maintain WBC count between 8000 and 15000/mm3. Doses may vary depending on regimens.
Dosage Details
Oral
Chronic myeloid leukaemia
Adult: Initial doses for remission induction: 1-2 mg daily. Maintenance: 0.25-0.75 mg every other day or twice wkly; adjust dose to maintain WBC count between 8000 and 15000/mm3. Doses may vary depending on regimens.
Action
Description: Carboquone, an alkylating agent, is used in the treatment of malignant neoplasms of the lung, stomach, ovary, lymphomas and in chronic myeloid leukaemia. It is usually administered by IV or intra-arterial route, or by mouth.
Disclaimer: This information is independently developed by MIMS based on Carboquone from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to MIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, MIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2020 MIMS. All rights reserved. Powered by MIMS.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in